Item 8.01 Other Events.
On April 20, 2020, Generex
Item 8.01 Other Events.
On April 20, 2020, Generex Biotechnology Corporation (“Generex”) received a letter of support from Tufts Medical Center regarding Generex’s efforts to develop Generex’s li-Key-SARS-CoV-2 peptide vaccine with the goal to begin mass vaccination in the Fall of 2020. A copy of the letter of support is attached to this report as Exhibit 99.1 and is incorporated by reference herein.
Tufts Medical Center is an internationally-respected academic medical center – a teaching hospital where it prides itself not only in the sophistication of the care it provides but the compassionate way in which Tufts Medical Center provides it. Tufts Medical Center cares for all patients from the tiniest newborns at its full-service pediatric hospital, Floating Hospital for Children, to centenarians in its specialized Geriatrics clinic. Tufts Medical Center is the principal teaching hospital for Tufts University School of Medicine. Tufts Medical Center conducts groundbreaking medical and health policy research and is in the top 10 percent of independent institutions receiving federal research funding.
2
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Another Triumph for Signals Intelligence Launches come and go, but HawkEye 360's recent deployment of Cluster 16 isn't just another tick on their list. This satellite trio is kitted out with tech that propels the firm deeper into the realm of signals intelligence, where every second counts. The Art of Keeping Up with Demand Now, it's no simple feat to manage rocket...
Continue Reading
Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...
Continue Reading
Cracking New Jersey's Complex Legal Code You ever try to decode the rulebook judges play by when gun possession and aggravated assault enter the picture in New Jersey? Well, it's as tricky as picking a safe with a wet noodle. Thankfully, a legal eagle named Ed Weinstock sheds some light on this murky terrain. Now, this isn't just some academic exercise—it's a look into...
Continue Reading
PlanetiQ Sets New Pace with Satellite Launches Another day, another launch, eh? PlanetiQ is on a roll! The commercial provider of GNSS radio occultation (GNSS-RO) weather data isn't just resting on its laurels. This October alone, the outfit has blasted two new satellites into the great beyond. That's right, partner—they're stacking assets like poker chips. Quick...
Continue Reading
Ah, poker. Where dreams are won with a flick of the wrist and a well-placed bluff. This week, it was all eyes on Americas Cardroom’s Dual Venom PKOs, and let me tell you, they didn't just meet expectations—they chewed them up and spat them out like yesterday's jam. Two Titans Crowned in Poker Showdown The action wrapped up with a jaw-dropping $6,862,500 prize pool....
Continue Reading
Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...
Continue Reading
Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...
Continue Reading
Storm Clouds Over Anavex: What Investors Need to Know If you've got a slice of Anavex Life Sciences Corp. (NASDAQ: AVXL) in your portfolio, the latest chapter of their legal saga feels less like a twist and more like a twist of the knife. These lawsuits often come out of left field for investors, but this one seems like a slow train that’s been gathering steam for a...
Continue Reading
FP Movement Expands with Style in Rhode Island FP Movement is shaking things up in Cranston, Rhode Island, bringing its signature activewear vibe to Garden City Center with a new shop. It’s not just about buying leggings anymore; it’s about diving into a lifestyle that screams energy and community spirit. The store, which spans 1,209 selling-square-feet, opened its...
Continue Reading
Malteurop’s Ambitious Leap into China Folks, it looks like Malteurop, the malting arm of the French VIVESCIA Group, is digging its French roots deep into Chinese soil with a move that screams strategy. They’ve just scooped up the Chunlei Malting Co. plant in Jiangsu province, which cranks out enough malt to sling two billion liters of beer annually. Yeah, that's quite...
Continue Reading
blog__more">
More News Articles